Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-09 · accession 0000950170-25-070568 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-05-13 | 2025-05-09 | TMDX | Basile Edward M | Dir | M - OptEx | $0.7 | +6,000 | 6,732 | +820% | +$4,200 |
| DT | 2025-05-13 | 2025-05-09 | TMDX | Basile Edward M | Dir | S - Sale+OE | $115.63 | -6,000 | 732 | -89% | -$693.8K |
| DT | 2025-05-13 | 2025-05-09 | TMDX | Basile Edward M | Dir | M - OptEx | — | -6,000 | 13.3K | -31% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-09 | M | A | 6,000 | $0.7 | 6,732 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-09 | S | D | 6,000 | $115.63 | 732 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-05-09 | M | D | 6,000 | — | 13,285 | D | $0.7 · — to 2026-02-16 | 6,000 Common Stock | (F2) The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. (F1) The option is fully vested. |